Anupam Rasayan Concludes Bliss GVS Acquisition With 48.2 Percent Controlling Stake

Anupam Rasayan completed acquisition of a 48.2% controlling stake in Bliss GVS Pharma at ₹299/share, funded by a ₹300 crore term loan and ~₹1,450 crore of non-controlling, non-voting instruments. The combined platform is expected to exceed ₹4,000 crore revenue with ~₹834 crore EBITDA. Context: Bliss acquisition overhang resolved.